The onkowissen Biosimilars app offers you digital, fast, simple and up-to-date access to extensive information on biosimilars. The app was developed in cooperation with interdisciplinary experts to ensure a comprehensive and up-to-date overview of biosimilars. The app presents modern educational content and offers links to current official information and interesting research articles.

The app includes the following content:
• Biosimilar Radar: A dynamic representation of relevant data from biosimilar oncology and anti-inflammatory therapeutics as well as the biosimilars of pegfilgrastim.
• Latest News: Receive links to the latest news, such as regulatory approval information or new biosimilar publications of interest.
• Production, safety and approval of biosimilars: The most important points on the respective content are presented briefly and concisely.
• Everyday issues: topics such as switches, cost structure and differences between generics and biosimilars are discussed.
• Statements: Here you will find references to the current statements from specialist societies, commissions, authorities and industry.
• Glossary: ​​The most important terms on the topic of biosimilars are explained in the glossary. The quick entry into the world of biosimilars.

The app also contains a news feed with links to new data and current topics related to biosimilars.

The app is for informational purposes only. It is intended only for specialist groups with an onkowissen.de login.